MACROGENICS INC's ticker is MGNX and the CUSIP is 556099109. A total of 177 filers reported holding MACROGENICS INC in Q1 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $59,000 | -31.4% | 19,920 | +271.6% | 0.00% | -33.3% |
| Q4 2021 | $86,000 | +53.6% | 5,361 | +101.9% | 0.00% | +50.0% |
| Q3 2021 | $56,000 | -74.5% | 2,655 | -67.5% | 0.00% | -71.4% |
| Q2 2021 | $220,000 | +1122.2% | 8,174 | +1331.5% | 0.01% | +600.0% |
| Q1 2021 | $18,000 | 0.0% | 571 | -10.4% | 0.00% | -50.0% |
| Q2 2020 | $18,000 | +800.0% | 637 | +102.9% | 0.00% | +100.0% |
| Q1 2020 | $2,000 | -93.5% | 314 | -81.6% | 0.00% | -91.7% |
| Q1 2019 | $31,000 | +520.0% | 1,708 | +339.1% | 0.01% | +500.0% |
| Q4 2018 | $5,000 | +150.0% | 389 | +357.6% | 0.00% | +100.0% |
| Q2 2018 | $2,000 | -95.8% | 85 | -95.5% | 0.00% | -96.0% |
| Q1 2018 | $48,000 | +4700.0% | 1,892 | +2642.0% | 0.02% | +2400.0% |
| Q4 2017 | $1,000 | -50.0% | 69 | -20.7% | 0.00% | 0.0% |
| Q3 2017 | $2,000 | +100.0% | 87 | +112.2% | 0.00% | 0.0% |
| Q2 2017 | $1,000 | 0.0% | 41 | -25.5% | 0.00% | 0.0% |
| Q1 2017 | $1,000 | 0.0% | 55 | +71.9% | 0.00% | 0.0% |
| Q4 2016 | $1,000 | – | 32 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,264,158 | $5,890,976 | 1.79% |
| Bellevue Group AG | 9,803,313 | $45,683,439 | 0.74% |
| Frazier Life Sciences Management, L.P. | 1,803,204 | $8,402,931 | 0.56% |
| DAFNA Capital Management LLC | 258,496 | $1,204,591 | 0.38% |
| SECTORAL ASSET MANAGEMENT INC | 387,001 | $1,803,425 | 0.35% |
| ARMISTICE CAPITAL, LLC | 4,712,000 | $21,957,920 | 0.34% |
| Rock Springs Capital Management LP | 1,178,796 | $5,493,189 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 225,918 | $1,053 | 0.09% |
| PINNACLE ASSOCIATES LTD | 697,067 | $3,248,332 | 0.06% |
| XTX Topco Ltd | 53,269 | $248,234 | 0.04% |